Quantcast

Latest Fexofenadine Stories

2014-08-24 23:00:38

LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Fexofenadine HCl Industry, 2009-2019” to its store. Inquire before buying this report at http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=9591. Dallas, TX (PRWEB) August 24, 2014 This is a professional and in-depth market survey on Global and Chinese Fexofenadine HCl industry. The report firstly reviews the basic information of Fexofenadine HCl including its...

2014-07-01 16:29:58

ALBANY, N.Y., July 1, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners, LLC. The transaction is consistent with AMRI's strategy to be the preeminent supplier of custom and complex drug product development and manufacturing services to the pharmaceutical industry. OsoBio is recognized as a premier contract manufacturer of highly complex...

2014-06-23 08:28:43

ALBANY, N.Y., June 23, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in connection with AMRI's proposed acquisition of Oso Biopharmaceuticals Manufacturing, LLC ("OsoBio") was terminated by the United States Federal Trade Commission on June 20, 2014. As previously announced on June 2, 2014, AMRI entered into a definitive agreement to acquire all of the outstanding...

2014-06-11 08:31:09

SAN FRANCISCO, June 11, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will host an Investor Breakfast on Friday, June 13, 2014 in New York City. Kindred Bio's executive management team will provide an overview of the Company's strategies and Stephen Sundlof, D.V.M, Ph.D., will offer insights into the animal health business from an FDA perspective. Dr. Sundlof was...

2014-04-04 08:25:56

SAN FRANCISCO, April 4, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will present at Needham 13(th) Annual Healthcare Conference in New York City: Presentation date: April 9, 2014 Presenting time: 12:10 PM ET Presentation location: Westin Grand Central Hotel, Ambassador Room The presentation will be webcast live over the Internet and can be accessed through the...

2014-03-04 12:25:47

SAN FRANCISCO, March 4, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will present at Roth Capital Partners 26(th) Annual Growth Stock Conference in Dana Point, CA: Presentation date: March 10, 2014 Presenting time: 1:30 PM PDT Presentation location: Ritz-Carlton, Salon 6 The presentation will be webcast live over the Internet and can be accessed...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'